Medline Europe will begin selling its range of Compass® digital pressure reading devices directly to customers in Switzerland this month, following success in other markets.

Starting 20 March, Compass® will be sold directly without a third-party vendor, providing customers with enhanced service and a broader product offering. The decision to sell directly in Switzerland is the latest development since the acquisition of Centurion Medical Products by Medline Industries Inc. in November 2019. The past few months have seen a successful launch and integration of the Compass product range in the United States, France, Belgium, Germany and Austria.

The range consists of three products, including:

• Compass® UniversalHG, a versatile, sterile and single-use digital pressure reading medical device used for the measurement of compartment pressure. Delays and misdiagnoses of compartment syndrome can cause nerve and tissue death and muscle damage, making early detection vitally important to treating and managing this issue
• Compass® Lumbar, useful in the measurement of cerebral spinal fluid pressure
• Compass® Thoracentesis, for measurement of pleural pressure.

All Compass® devices provide a simple, precise and indisputable digital pressure reading instantly.

To ensure an effective launch, the Swiss Medline team is focusing on educating Medline customers and promoting these products with instructional and informative brochures and videos.

To learn more about Compass® products, please visit our page where you can see our product video. It is also possible to contact us for more information by sending an email to [email protected]

Last week, Medline Europe representatives from France, Slovakia and the European headquarters in the Netherlands had the privilege to attend a meeting in Partizánske, Slovakia, with the local mayor to discuss an upcoming expansion project in Slovakia.

This meeting grabbed the attention of the national press due to the project’s projected local impact (you can watch the coverage in the Slovak language here).

The planned facility will represent an investment of €24 million and create around 300 new jobs for the local community in addition to the 200 people already employed by Medline in Slovakia. Medline is committed to continue being an active participant in Slovakia’s economy, and this project will enable the company to increase its footprint in Europe, expand sales into Eastern Europe and further address customer needs. Production in the new facility is scheduled to begin in early 2022.